Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Feb 1;19(2):190-225.
doi: 10.1093/europace/euw242.

European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS)

Bulent Gorenek  1 , Antonio Pelliccia  2 , Emelia J Benjamin  3 , Giuseppe Boriani  4 , Harry J Crijns  5 , Richard I Fogel  6 , Isabelle C Van Gelder  7 , Martin Halle  8 , Gulmira Kudaiberdieva  9 , Deirdre A Lane  10 , Torben Bjerregaard Larsen  11 , Gregory Y H Lip  10 , Maja-Lisa Løchen  10   11 , Francisco Marín  12 , Josef Niebauer  13 , Prashanthan Sanders  14 , Lale Tokgozoglu  15 , Marc A Vos  16 , David R Van Wagoner  17 , Laurent Fauchier  18 , Irina Savelieva  19 , Andreas Goette  20 , Stefan Agewall  21 , Chern-En Chiang  22 , Márcio Figueiredo  23 , Martin Stiles  24 , Timm Dickfeld  25 , Kristen Patton  26 , Massimo Piepoli  27 , Ugo Corra  28 , Pedro Manuel Marques-Vidal  29 , Pompilio Faggiano  30 , Jean-Paul Schmid  31 , Ana Abreu  32
Affiliations
Review

European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS)

Bulent Gorenek et al. Europace. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Graph showing time to occurrence of symptomatic atrial fibrillation in all 169 patients with paroxysmal supraventricular tachycardia. Y-Axis reflects the percentage of patients free from atrial fibrillation. (Reprinted from reference 277: J Am Coll Cardiol Vol.25, Hamer ME, Wilkinson WE, Clair WK, Page RL, McCarthy EA, Pritchett EL. Incidence of symptomatic atrial fibrillation in patients with paroxysmal supraventricular tachycardia. number, p. 984–8, Copyright 1995, with permission from Elsevier.)
Figure 2
Figure 2
Management of supraventricular tachycardias causing AF. AF, atrial fibrillation; AAD, antiarrhythmic drug; PAF, paroxysmal AF; SVT, supraventricular tachycardia.
Figure 3
Figure 3
Lifetime approach to primary prevention of AF. AF, atrial fibrillation.
See this image and copyright information in PMC

References

    1. Wolf PA, Dawber TR, Thomas HE Jr, Kannel WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham Study. Neurology 1978;28:973–7. - PubMed
    1. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-up Study. Am J Med 1995;98:476–84. - PubMed
    1. Ott A, Breteler MM, de Bruyne MC, van Harskamp F, Grobbee DE, Hofman A. Atrial fibrillation and dementia in a population-based study: the Rotterdam Study. Stroke 1997;28:316–21. - PubMed
    1. Miyasaka Y, Barnes ME, Petersen RC, Cha SS, Bailey KR, Gersh BJ et al. . Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a community-based cohort. Eur Heart J 2007;28:1962–7. - PubMed
    1. Soliman EZ, Lopez F, O'Neal WT, Chen LY, Bengtson L, Zhang ZM et al. . Atrial fibrillation and risk of ST-segment-elevation versus non-ST-segment-elevation myocardial infarction: The Atherosclerosis Risk in Communities (ARIC) study. Circulation 2015;131:1843–50. - PMC - PubMed